NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Kodikaz Therapeutic Solutions Inc.

Kodikaz Therapeutic Solutions Inc.

Private
New York City, New YorkHealthcare & Life Scienceshttps://kodikaz.com/

Last Round

VC Round

May 21, 2024

Total Funding Raised

$255,831

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Kodikaz Therapeutic Solutions Inc. is a biotechnology company developing a gene therapy platform for cancer treatment.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Precision Medicine, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting, Revenue Share, Government Contracts

AI Layer

Non-AI

Keywords

non-viral deliverygene therapydrug delivery platformcell-specific deliverynucleic acid therapeuticsoncologyRNA deliveryDNA deliverytargeted drug deliverycancer gene therapybiotech licensingpre-clinical biotechZip-Code TechnologySBIRSmall Business Innovation Research

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Kodikaz Therapeutic Solutions Inc. Comps

Public and private peers based on sector, stage, and business model.

Kodikaz Therapeutic Solutions Inc. comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Kodikaz Therapeutic Solutions Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundMay 21, 2024
GrantAug 15, 2021

Kodikaz Therapeutic Solutions Inc. Investors

Notable investors and investment history

Kodikaz Therapeutic Solutions Inc. investors
InvestorRounds
Epidarex CapitalVC Round
Georgia Research AllianceVC Round
AmorChemVC Round
National Science FoundationGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 22, 2026

    Monthly visitors grew 416% MoM, from 263 to 1.4K.

  • Jan 21, 2026

    Monthly visitors increased 70% MoM, reaching 1.3K.

Kodikaz Therapeutic Solutions Inc. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Kodikaz Therapeutic Solutions Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Kodikaz Therapeutic Solutions Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersNew York City, New York
Employee Range8
Year Founded2018
Last FundingMay 21, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.